Long-Term Effects of COVID-19 Pandemic on Migraine in Adolescents. A Retrospective Analysis of the Population Attending the Headache Center in Different Phases of the Pandemic

Overview

Journal Brain Sci

Publisher MDPI

Date 2023 Feb 25

PMID 36831817

Authors

Martina Proietti Checchi

Samuela Tarantino

Fabiana Ursitti

Gabriele Monte

Romina Moavero

Giorgia Sforza

Michela Ada Noris Ferilli

Teresa Grimaldi Capitello

Federico Vigevano

Massimiliano Valeriani

Laura Papetti

Affiliations

Soon will be listed here.

Abstract

Background: Literature data report that the first COVID-19 pandemic had an impact on the progression of migraine both in adults and children. The present study aimed to verify how the migraine course and psychological aspects varied in adolescent patients in relation to some of the different phases of the COVID-19 pandemic and compared with the months before COVID-19. In addition, the relationship between the characteristics of headache episodes and psychological and school-related aspects were analyzed.

Methods: The study included 418 adolescents. Based on the timing of the evaluation, they were categorized into patients observed before the COVID-19 pandemic (pre COVID) or during the first (COVID 1) or second (COVID 2) wave of the pandemic. Subjects were also categorized into three further groups: those who had high or low frequency of migraine attacks during the month, those who had mild or severe pain during the attack, and those who were taking prophylactic drugs. The Patient Health Questionnaire-9 (PHQ-9) and General Anxiety Disorder-7 (GAD-7) scales were utilized to assess depression and anxiety.

Results: We observed a significant increase in the frequency of attacks and the use of prophylactic drugs during the COVID 2 period compared to the COVID 1 and pre-COVID periods ( < 0.05). Patients showed higher levels of anxiety and depression during each of the two COVID periods compared with the pre-COVID months ( < 0.05), especially during the COVID 2 period ( < 0.05).

Conclusion: Our results show long-term negative impacts of the COVID-19 pandemic on clinical parameters and psychological symptoms in adolescents with migraine.

References

Manea L, Gilbody S, McMillan D . Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. CMAJ. 2011; 184(3):E191-6. PMC: 3281183. DOI: 10.1503/cmaj.110829. View

Kaczynski K, Chang C, Chimoff J, Koike C, Berde C, Logan D . Initial Adjustment to the COVID-19 Pandemic and the Associated Shutdown in Children and Adolescents With Chronic Pain and Their Families. Front Pain Res (Lausanne). 2022; 2:713430. PMC: 8915775. DOI: 10.3389/fpain.2021.713430. View

Shah S, Moore E, Robertson C, McMenamin J, Katikireddi S, Simpson C . Predicted COVID-19 positive cases, hospitalisations, and deaths associated with the Delta variant of concern, June-July, 2021. Lancet Digit Health. 2021; 3(9):e539-e541. PMC: 8352493. DOI: 10.1016/S2589-7500(21)00175-8. View

Papetti L, Alaimo di Loro P, Tarantino S, Grazzi L, Guidetti V, Parisi P . I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children. Cephalalgia. 2020; 40(13):1459-1473. PMC: 7684684. DOI: 10.1177/0333102420965139. View

Tarantino S, De Ranieri C, Dionisi C, Gagliardi V, Paniccia M, Capuano A . Role of the Attachment Style in Determining the Association Between Headache Features and Psychological Symptoms in Migraine Children and Adolescents. An Analytical Observational Case-Control Study. Headache. 2017; 57(2):266-275. DOI: 10.1111/head.13007. View

Suzuki K, Takeshima T, Igarashi H, Imai N, Danno D, Yamamoto T . Impact of the COVID-19 pandemic on migraine in Japan: a multicentre cross-sectional study. J Headache Pain. 2021; 22(1):53. PMC: 8182734. DOI: 10.1186/s10194-021-01263-1. View

Ford T, Cross L . Debate: Is there a true global children and young people's mental health crisis, fact or fiction?. Child Adolesc Ment Health. 2021; 26(3):272-273. DOI: 10.1111/camh.12483. View

Oskoui M, Pringsheim T, Billinghurst L, Potrebic S, Gersz E, Gloss D . Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019; 93(11):500-509. PMC: 6746206. DOI: 10.1212/WNL.0000000000008105. View

McElroy E, Patalay P, Moltrecht B, Shevlin M, Shum A, Creswell C . Demographic and health factors associated with pandemic anxiety in the context of COVID-19. Br J Health Psychol. 2020; 25(4):934-944. DOI: 10.1111/bjhp.12470. View

10.

Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

11.

Dallavalle G, Pezzotti E, Provenzi L, Toni F, Carpani A, Borgatti R . Migraine Symptoms Improvement During the COVID-19 Lockdown in a Cohort of Children and Adolescents. Front Neurol. 2020; 11:579047. PMC: 7578413. DOI: 10.3389/fneur.2020.579047. View

12.

Parodi I, Poeta M, Assini A, Schirinzi E, Del Sette P . Impact of quarantine due to COVID infection on migraine: a survey in Genova, Italy. Neurol Sci. 2020; 41(8):2025-2027. PMC: 7329264. DOI: 10.1007/s10072-020-04543-x. View

13.

Qi M, Zhou S, Guo Z, Zhang L, Min H, Li X . The Effect of Social Support on Mental Health in Chinese Adolescents During the Outbreak of COVID-19. J Adolesc Health. 2020; 67(4):514-518. PMC: 7395830. DOI: 10.1016/j.jadohealth.2020.07.001. View

14.

Lahav E, Rosenboim M, Shahrabani S, Song Y . Optimism and precautionary measures during the COVID-19 outbreak in China. Am J Health Behav. 2021; 45(6):978-992. DOI: 10.5993/AJHB.45.6.3. View

15.

Lipton R, Bigal M . Migraine: epidemiology, impact, and risk factors for progression. Headache. 2005; 45 Suppl 1:S3-S13. DOI: 10.1111/j.1526-4610.2005.4501001.x. View

16.

Delussi M, Gentile E, Coppola G, Prudenzano A, Rainero I, Sances G . Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe). Front Neurol. 2020; 11:597881. PMC: 7683429. DOI: 10.3389/fneur.2020.597881. View

17.

Bauerle A, Teufel M, Musche V, Weismuller B, Kohler H, Hetkamp M . Increased generalized anxiety, depression and distress during the COVID-19 pandemic: a cross-sectional study in Germany. J Public Health (Oxf). 2020; 42(4):672-678. PMC: 7454766. DOI: 10.1093/pubmed/fdaa106. View

18.

Bera L, Souchon M, Ladsous A, Colin V, Lopez-Castroman J . Emotional and Behavioral Impact of the COVID-19 Epidemic in Adolescents. Curr Psychiatry Rep. 2022; 24(1):37-46. PMC: 8803571. DOI: 10.1007/s11920-022-01313-8. View

19.

Heras E, Garibaldi P, Boix M, Valero O, Castillo J, Curbelo Y . COVID-19 mortality risk factors in older people in a long-term care center. Eur Geriatr Med. 2020; 12(3):601-607. PMC: 7693854. DOI: 10.1007/s41999-020-00432-w. View

20.

Oosterhoff B, Palmer C, Wilson J, Shook N . Adolescents' Motivations to Engage in Social Distancing During the COVID-19 Pandemic: Associations With Mental and Social Health. J Adolesc Health. 2020; 67(2):179-185. PMC: 7205689. DOI: 10.1016/j.jadohealth.2020.05.004. View